Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model

Artificial Organs

Volumn 27, Issue 7, 2003, Pages 613-622

  Chen, Zhong ^a,b   Ding, Yitao ^b   Xu, Qingxiang ^b   Yu, Decai ^b  

^a NANTONG MEDICAL COLLEGE   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Bioartificial liver; Canine; Culture; Liver failure; Model; Porcine hepatocyte

Indexed keywords

AMINO ACIDS; AMMONIA; BLOOD; PHOSPHATASES;

ACUTE LIVER FAILURE; AFTER-TREATMENT; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BIOARTIFICIAL LIVER; CANINE; CULTURE; HEPATOCYTES; LIVER FAILURE; PORCINE HEPATOCYTE;

ARTIFICIAL ORGANS;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMMONIA; AROMATIC AMINO ACID; BILIRUBIN;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL LIVER; BILIRUBIN BLOOD LEVEL; BLOOD LEVEL; CONTROLLED STUDY; DOG; FEMALE; INOCULATION; LIVER CELL; LIVER FAILURE; MALE; NONHUMAN; ORGAN PERFUSION; PRIORITY JOURNAL; PROTHROMBIN TIME; SPHEROID CELL; SURVIVAL;

ANIMALIA; CANIS FAMILIARIS; SUIDAE;

EID: 0038574525     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2003.07140.x     Document Type: Article

References (46)

1. Nagaki M, Miki K, Kim Y, Ishiyama H, Hirahara I, Takahashi H, Sugiyama A, Muto Y, Moriwaki H. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig Dis Sci 2001;46:1046-56.
2. Chen Z, Ding Y, Zhang H. Morphology, viability and functions of suckling pig hepatocytes cultured in serum-free medium at high density. Dig Surg 2002;19:184-91.
3. Uchino J, Tsuburaya T, Kumagai F, Hase T, Hamada T, Komai T, Funatsu A, Hashimura E, Nakamura K, Kon T. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans 1988;34:972-7.
4. Cuervas-Mons V, Colas A, Rivera JA, Prados E. In vivo efficacy of a bioartificial liver in improving spontaneous recovery from fulminant hepatic failure: a controlled study in pigs. Transplantation 2000;69:337-44.
5. Sielaff TD, Hu MY, Amiot B, Rollins MD, Rao S, McGuire B, Bloomer JR, Hu WS, Cerra FB. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res 1995;59:179-84.
6. Sheil AGR, Sun J, Wang L, Rao N, Mears DC, Wang C, Woodman K, Johnston B, Watson J. Biodialysis: a new liver support system. Transplant Proc 1999;31:3258-9.
7. Gerlach JC, Botsch M, Kardassis D, Lemmens P, Schon M, Janke J, Puhl G, Unger J, Kraemer M, Busse B, Bohmer C, Belal R, Ingenlath M, Kosan M, Kosan B, Sultmann J, Patzold A, Tietze S, Rossaint R, Muller C, Monch E, Sauer IM, Neuhaus P. Experimental evaluation of a cell module for hybrid liver support. Int J Artif Organs 2001;24:793-8.
8. Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, Gislason GT, Sussman NL, Williams R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996;24:1446-51.
9. Watanabe FD, Mullon CJ-P, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997;225:484-94.
10. Chen SC, Mullon C, Kahaku E, Watenabe F, Hewitt W, Eguchi S, Middleton Y, Arkadopoulos N, Rozga J, Solomon B, Demetriou AA. Treatment of severe liver failure with a bioartificial liver. Ann N Y Acad Sci 1997;831:350-60.
11. Patzer JF, Lopez RC, Zhu Y, Wang ZF, Mazariegos GV, Fung JJ. Bioartificial liver assist devices in support of patients with liver failure. HBPD INT 2002;1:18-25.
12. Gerlach JC. Development of a hybrid liver support system: a review. Int J Artif Organs 1996;19:645-54.
13. McLaughlin BE, Tosone CM, Custer LM, Mullon C. Overview of extracorporeal liver support systems and clinical results. Ann N Y Acad Sci 1999;875:310-25.
14. Pahernik SA, Thasler WE, Doser M, Gomez-Lechon MJ, Castell MJ, Planck H, Koebe HG. High density culturing of porcine hepatocytes immobilized on nonwoven polyurethane-based biomatrices. Cell Tissues Organs 2001;168:170-7.
15. Flendrig LM, la Soe JW, Jorning GGA, Steenbeek A, Karlsen OT, Bovee WMMJ, Ladiges NCJJ, te Velde AA, Chamuleau RAFM. In vivo evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997;26:1379-92.
16. Awad SS, Hemmila MR, Soldes OS, Sawada S, Rich PB, Mahler S, Gargulinski M, Hirschl RB, Barlett RH. A novel stable reproducible model of hepatic failure in canines. J Surg Res 2000;94:167-71.
17. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976;13:29-83.
18. Chen Z, Ding Y, Zhang H. Cryopreservation of suckling pig hepatocytes. Ann Clin Lab Sci 2001;31:391-8.
19. Tong JZ, De Lagausie P, Furlan V, Cresteil T, Bernard O, Alvarez F. Long-term culture adult rat hepatocyte spheroid. Exp Cell Res 1992;200:326-32.
20. Rosen HM, Yoshimura N, Hodgman JM, Fischer JE. Plasma amino acid patterns in hepatic encephalopathy of different etiology. Gastroenterology 1977;72:483-7.
21. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994;18:355-62.
22. Matsubara S. Combination of plasma exchange and continuous hemofiltration as temporary metabolic support for patients with acute liver failure. Artif Organs 1994;18:363-6.
23. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Lohr M, Liebe S, Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
24. Steczko J, Ash SR, Blake DE, Carr DJ, Bosley RH. Cytokines and endotoxin removal by absorbents and its application in push-pull sorbent-based pheresis: the biologic-DTPF system. Artif Organs 1999;23:310-8.
25. Xue YL, Zhao SF, Zhang ZY, Wang YF, Li XJ, Huang XQ, Luo Y, Huang YC, Liu CG. Effects of a bioartificial liver support system on acetaminophen-induced acute liver failure canines. World J Gastroenterol 1999;5:308-11.
26. Fraslin JM, Kneip B, Vaulout S, Glaise D, Munnich A, Guguen-Guillionzo C. Dependence of hepatocyte-specific gene expression on cell-cell interactions in primary culture. EMBO J 1985;4:2487-91.
27. Hamamoto R, Yamada K, Kamihira M, Iijima S. Differentiation and proliferation of primary rat hepatocytes cultured as spheroids. J Cell Biol 1998;124:972-9.
28. Landry J, Bernier D, Ouellet C, Goyette R, Marceau N. Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol 1985;101:914-23.
29. Bissell DM, Arenson DM, Maher JJ, Roll FJ. Support of cultured hepatocytes by a laminin-rich gel: evidence for a functionally significant subendothelial matrix in normal rat liver. J Clin Invest 1987;79:801-12.
30. Koide N, Sakaguchi K, Koide Y, Asano K, Kawaguchi M, Matsushuma H, Takenami T, Shiji Y, Mori M, Tsuji T. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 1990;186:227-35.
31. Tobe S, Takei Y, Kobayashi K, Akaike T. Receptor-mediated formation of multiplayer aggregates of primary cultures adult rat hepatocytes on lactose-substituted polystyrene. Biochem Biophys Res Commun 1992;184:225-30.
32. Wu FJ, Friend JR, Lazar A, Mann HJ, Remmel RP, Cerra FB, Hu WS. Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol Bioeng 1996;52:34-44.
33. Wu FJ, Friend JR, Remmel RP, Cerra FB, Hu WS. Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant 1999;8:233-46.
34. Shiraha H, Koide N, Hada H, Ujike K, Nakamura M, Shinji T, Gotoh S, Tsuji T. Improvement of serum amino acid profile in hepatic failure with the bioartificial liver using multicellular hepatocyte spheroids. Biotech Bioeng 1996;50:416-21.
35. Sakai Y, Naruse K, Nagashima I, Muto T, Suzuki M. A new bioartificial liver using porcine hepatocyte spheroids in high-cell-density suspension perfusion culture: in vitro performance in synthesized culture medium and in 100% human plasma. Cell Transplant 1999;8:531-41.
36. Koide N, Sakaguchi K, Koide Y, Asano K, Kawaguchi M, Matsushima H, Takenami T, Shinji T, Mori M, Tsuji T. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res 1990;186:227-35.
37. Terblanche J, Hickman R. Animal models of fulminant hepatic failure. Dig Dis Sci 1991;36:770-4.
38. Blitzer BL, Waggoner JG, Jones EA, Gralnick HR, Towne D, Butler J, Weise V, Kopin IJ, Walters I, Teychenne PE, Goodman DG, Berk PD. A model of fulminant hepatic failure in the rabbit. Gastroenterology 1978;74:664-71.
39. Detry O, Arkadopoulos N, Ting P, Kahaku E, Watanabe FD, Rozga J, Demetriou AA. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am Surg 1999;65:934-8.
40. Kalpana K, Ong HS, Soo KC, Tan SY, Rai JP. An improved model of galactosamine-induced fulminant hepatic failure in the pig. J Surg Res 1999;82:121-30.
41. Eguchi S, Kamlot A, Ljubimova J, Hewitt WR, Lebow LT, Demetriou AA, Rozga J. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology 1996;24:1452-9.
42. Shito M, Balis V, Tompkins RG, Yarmush ML, Toner M. A fulminant hepatic failure model in the rat: improvement of interleukin-1 β and tumor necrosis factor-α. Dig Dis Sci 2001;46:1700-8.
43. Naruse K, Sakai Y, Lei G, Sakamoto Y, Kobayashi T, Puliatti C, Aronica G, Morale W, Leone F, Qing S, Ming SG, Ming S, Li Z, Chang SJ, Suzuki M, Makuuchi M. Efficacy of nonwoven fabric bioreactor immobilized with porcine hepatocytes for ex vivo xenogeneic perfusion treatment of liver failure in dogs. Artif Organs 2001;25:273-80.
44. Fischer JE. Plasma amino acids in patients with hepatic encephalopathy. Effect of amino acid infusions. Am J Surg 1974;127:40-7.
45. Stefanovich P, Matthew HWT, Toner M, Tompkins RG, Yarmush ML. Extracorporeal plasma perfusion of cultured hepatocytes: effect of intermittent perfusion on hepatocyte function and morphology. J Surg Res 1996;66:57-63.
46. Khalili TM, Navarro A, Ting P, Kamohara Y, Arkadopoulos N, Solomon BA, Demetriou AA, Rozga J. Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure. Artif Organs 2001;25:566-70.